https://www.selleckchem.com/products/azd0364.html
Past respiratory viral epidemics suggest that bacterial infections impact clinical outcomes. There is minimal information on potential co-pathogens in patients with coronavirus disease-2019 (COVID-19) in the US. We analyzed pathogens, antimicrobial use, and healthcare utilization in hospitalized US patients with and without severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). This multicenter retrospective study included patients with 1 day of inpatient admission and discharge/death between March 1 and May 31, 2020 at 241
Curtir
Comentario
Compartilhar
